Please Wait

Applying Filters...

Looking for NCGC00024708-03? Find Controlled & Modified Release used in NCGC00024708-03 to address drug delivery challenges on PharmaCompass.

NCGC00024708-03

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 8 USDMF, 4 EU WC, 7 NDC API, 12 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 11 FDA Orange Book, 3 Europe, 2 Canada, 4 Australia, 1 South Africa, 14 Listed Dossiers

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 6 Gangwal Healthcare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ingredion Pharma Solutions, 1 Kerry, 5 Microlex e.U, 2 Pluviaendo, 1 Prachin Chemical, 6 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

19 Fillers, Diluents & Binders, 9 Direct Compression, 8 Lubricants & Glidants, 6 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 3 Taste Masking, 3 Thickeners and Stabilizers, 3 Chewable & Orodispersible Aids, 2 Controlled & Modified Release, 1 Coating Systems & Additives, 1 Emulsifying Agents, 1 Granulation

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 Health Canada Patents

12 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls

Filters

NCGC00024708-03

Filters

FILTER :

filter Company Reset all filters

3 All

01 2Gangwal Healthcare

02 1Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Gangwal Healthcare

India

CPhI Worldwide, Milan

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : DiCOM-DC® SR300

Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Brand : DICOM-DC® SR300

Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

Gangwal Healthcare DiCOM-DC® SR300

Excipients Web Link

Digital Content

02

Kerry

Formnext Forum

Not Confirmed